Modern antihyperglycemic therapy: safety and efficacy of glimepiride
Current review analyzes pharmacological and clinical aspects of glimepiride from perspective of the evidence-based medicine. We aimedto determine position of glimepiride within modern antihyperglycemic dialectics of safety and efficacy. We also address cardioprotectiveproperties of glimeperide due t...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7e0a54b9cd51417cbf3ed787ad5c41a0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7e0a54b9cd51417cbf3ed787ad5c41a0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7e0a54b9cd51417cbf3ed787ad5c41a02021-11-14T09:00:17ZModern antihyperglycemic therapy: safety and efficacy of glimepiride2072-03512072-037810.14341/2072-0351-5525https://doaj.org/article/7e0a54b9cd51417cbf3ed787ad5c41a02012-06-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5525https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Current review analyzes pharmacological and clinical aspects of glimepiride from perspective of the evidence-based medicine. We aimedto determine position of glimepiride within modern antihyperglycemic dialectics of safety and efficacy. We also address cardioprotectiveproperties of glimeperide due to its anti-atherogenic activity, capacity to correct endothelial dysfunction and hemostatic system, as wellas absence of inhibitory effect on ischemic preconditioning.Lyudmila Alexandrovna RuyatkinaMaksim Yur'evich SorokinEndocrinology Research Centrearticlediabetes mellitus type 2sulphonylureaglimepiridecardioprotectionantihyperglycemic safetyNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 15, Iss 2, Pp 89-97 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN RU |
topic |
diabetes mellitus type 2 sulphonylurea glimepiride cardioprotection antihyperglycemic safety Nutritional diseases. Deficiency diseases RC620-627 |
spellingShingle |
diabetes mellitus type 2 sulphonylurea glimepiride cardioprotection antihyperglycemic safety Nutritional diseases. Deficiency diseases RC620-627 Lyudmila Alexandrovna Ruyatkina Maksim Yur'evich Sorokin Modern antihyperglycemic therapy: safety and efficacy of glimepiride |
description |
Current review analyzes pharmacological and clinical aspects of glimepiride from perspective of the evidence-based medicine. We aimedto determine position of glimepiride within modern antihyperglycemic dialectics of safety and efficacy. We also address cardioprotectiveproperties of glimeperide due to its anti-atherogenic activity, capacity to correct endothelial dysfunction and hemostatic system, as wellas absence of inhibitory effect on ischemic preconditioning. |
format |
article |
author |
Lyudmila Alexandrovna Ruyatkina Maksim Yur'evich Sorokin |
author_facet |
Lyudmila Alexandrovna Ruyatkina Maksim Yur'evich Sorokin |
author_sort |
Lyudmila Alexandrovna Ruyatkina |
title |
Modern antihyperglycemic therapy: safety and efficacy of glimepiride |
title_short |
Modern antihyperglycemic therapy: safety and efficacy of glimepiride |
title_full |
Modern antihyperglycemic therapy: safety and efficacy of glimepiride |
title_fullStr |
Modern antihyperglycemic therapy: safety and efficacy of glimepiride |
title_full_unstemmed |
Modern antihyperglycemic therapy: safety and efficacy of glimepiride |
title_sort |
modern antihyperglycemic therapy: safety and efficacy of glimepiride |
publisher |
Endocrinology Research Centre |
publishDate |
2012 |
url |
https://doaj.org/article/7e0a54b9cd51417cbf3ed787ad5c41a0 |
work_keys_str_mv |
AT lyudmilaalexandrovnaruyatkina modernantihyperglycemictherapysafetyandefficacyofglimepiride AT maksimyurevichsorokin modernantihyperglycemictherapysafetyandefficacyofglimepiride |
_version_ |
1718429589486698496 |